Gypenoside attenuates hepatic ischemia/reperfusion injury in mice via anti-oxidative and anti-apoptotic bioactivities

  • Authors:
    • Jie Zhao
    • Yingzi Ming
    • Qiquan Wan
    • Shaojun Ye
    • Song Xie
    • Yi Zhu
    • Yanfeng Wang
    • Zibiao Zhong
    • Ling Li
    • Qifa Ye
  • View Affiliations

  • Published online on: February 21, 2014     https://doi.org/10.3892/etm.2014.1569
  • Pages: 1388-1392
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Gynostemma pentaphyllum is a traditional Chinese medicine that has previously been used for the treatment of chronic inflammation, hyperlipidemia and liver disease. Gypenoside (GP), the predominant component of Gynostemma pentaphyllum, exhibits a therapeutic effect on chronic hepatic injury, fibrosis and fatty liver disease via its anti-inflammatory and anti‑oxidant activity. However, the effect of GP on ischemia/reperfusion (I/R)-induced hepatic injury has, to the best of our knowledge, not previously been investigated. In the present study, a hepatic I/R‑injury model was successfully established using C57BL/6 mice. In the treatment group, 50 mg/kg GP was administered orally 1 h prior to ischemia. Following hepatic I/R, the levels of hepatic lipid peroxidation and serum alanine aminotransferase increased, while the ratio of hepatic glutathione (GSH):oxidized GSH was reduced, which was effectively attenuated by pretreatment with GP. Furthermore, an increased protein expression of heme oxygenase-1 in the liver tissues of the I/R mice was attenuated by the administration of GP. In addition, the present study indicated that treatment with GP suppressed the I/R-induced increase in the pro-apoptotic protein levels of Bax and cytochrome c and the activity of caspase-3/8, as well as the I/R-induced decrease in the levels of anti-apoptotic protein Bcl‑2. In conclusion, the present study indicated that GP effectively protected against I/R-induced hepatic injury via its anti-oxidative and anti-apoptotic bioactivity.
View Figures
View References

Related Articles

Journal Cover

May-2014
Volume 7 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhao J, Ming Y, Wan Q, Ye S, Xie S, Zhu Y, Wang Y, Zhong Z, Li L, Ye Q, Ye Q, et al: Gypenoside attenuates hepatic ischemia/reperfusion injury in mice via anti-oxidative and anti-apoptotic bioactivities. Exp Ther Med 7: 1388-1392, 2014
APA
Zhao, J., Ming, Y., Wan, Q., Ye, S., Xie, S., Zhu, Y. ... Ye, Q. (2014). Gypenoside attenuates hepatic ischemia/reperfusion injury in mice via anti-oxidative and anti-apoptotic bioactivities. Experimental and Therapeutic Medicine, 7, 1388-1392. https://doi.org/10.3892/etm.2014.1569
MLA
Zhao, J., Ming, Y., Wan, Q., Ye, S., Xie, S., Zhu, Y., Wang, Y., Zhong, Z., Li, L., Ye, Q."Gypenoside attenuates hepatic ischemia/reperfusion injury in mice via anti-oxidative and anti-apoptotic bioactivities". Experimental and Therapeutic Medicine 7.5 (2014): 1388-1392.
Chicago
Zhao, J., Ming, Y., Wan, Q., Ye, S., Xie, S., Zhu, Y., Wang, Y., Zhong, Z., Li, L., Ye, Q."Gypenoside attenuates hepatic ischemia/reperfusion injury in mice via anti-oxidative and anti-apoptotic bioactivities". Experimental and Therapeutic Medicine 7, no. 5 (2014): 1388-1392. https://doi.org/10.3892/etm.2014.1569